Nu Skin Enterprises Reports Strong Q1 2025 Results

Tip Ranks
2025.05.09 04:11

Nu Skin Enterprises (NUS) reported its Q1 2025 earnings, revealing a revenue of $364.5 million, a 12.7% decrease from the previous year. Despite this decline, earnings per share rose to $2.14 due to a gain from the sale of Mavely, contributing to a net income of $107.5 million. The company noted a decrease in gross margin to 67.8% and reduced selling expenses to 32.5%. Looking ahead, Nu Skin projects Q2 revenue between $355 million and $390 million, while maintaining its annual guidance amid macroeconomic uncertainties.

Nu Skin Enterprises ( (NUS) ) has released its Q1 earnings. Here is a breakdown of the information Nu Skin Enterprises presented to its investors.

Nu Skin Enterprises Inc. is a global beauty and wellness company that operates in nearly 50 markets worldwide, offering a range of personal care, nutrition, and anti-aging products through its dynamic affiliate platform.

In its first quarter of 2025, Nu Skin Enterprises reported revenue at the high end of its guidance range, despite a decline compared to the previous year. The company achieved a revenue of $364.5 million, marking a 12.7% decrease from the prior-year quarter, with a notable foreign exchange impact. Earnings per share stood at $2.14, significantly higher than the previous year’s loss, driven by a gain from the sale of Mavely.

Key financial metrics revealed a decrease in gross margin to 67.8% and a reduction in selling expenses to 32.5%. The company also reported a substantial gain on the sale of Mavely, contributing to a net income of $107.5 million. Despite challenges in consumer demand for premium beauty products, Nu Skin saw growth in Latin America and its Rhyz manufacturing segment. The company is preparing for the launch of its Prysm iO wellness device and expansion into the Indian market.

Looking ahead, Nu Skin Enterprises remains focused on improving margins and expanding its market presence. The company projects second-quarter revenue between $355 million and $390 million, with earnings per share expected to range from $0.20 to $0.30. Despite macroeconomic uncertainties, Nu Skin maintains its adjusted annual guidance, emphasizing cost efficiency and strategic growth initiatives.

Trending Articles:

  • Investor Waves Caution Flag on Archer Aviation Stock: ‘Too Many Ifs’
  • Palantir Stock Jumps: Here’s What This Top Investor Predicts Next
  • “Reshape..the Notion of Premium” Paramount Stock (NASDAQ:PARA) Notches up With Upfront Breakup

Disclaimer & DisclosureReport an Issue

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.